Gloria Chui joined Rebus Biosystems as Principal Scientist, Reagent Products in 2021. She brings 25 years of research and development experience in biochemistry, genomics and IVD product development to the company. Gloria is responsible for the development of chemistry and reagent product consumables for the Rebus Esper High Fidelity Assay platforms. Prior to joining Rebus, she was Staff Scientist at Applied Biosystems and Guardant Health leading the reagent development efforts in sequencing and genomics operations for molecular and cancer diagnostic products. She was also process development lead and system engineering lead for a blood cancer diagnostic CE-IVD project at BD Biosciences. Gloria received her PhD in Biochemistry and Molecular Biology at UC Berkeley and completed her post-doctoral training in Biochemistry at Stanford University.